Purpura, Thrombocytopaenic, Idiopathic

Drug Use Investigation for REVOLADE (ITP)

Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag

Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag

EXTEND (Eltrombopag Extended Dosing Study)

LENS - Long-term Eltrombopag Observational Study

Promacta Pregnancy Registry

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.

Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)